clinical/translational research - UNC School of Medicine
... B: Clinical track fellows will have 0.5 day in one clinic of interest (e.g. GI) and then rotate through the areas (breast, thoracic, etc) for more prolonged exposure ...
... B: Clinical track fellows will have 0.5 day in one clinic of interest (e.g. GI) and then rotate through the areas (breast, thoracic, etc) for more prolonged exposure ...
The American Cancer Society`s Research Program
... Contemporary cancer research is poised to make great advances in the coming decade in the areas of: • Drugs designed to attack cancer at its genetic roots, e.g., anti-telomerase, proapoptosis, anti-angiogenesis • Immunotherapy--therapeutic vaccines and monoclonal antibodies • Chemoprevention • Gene ...
... Contemporary cancer research is poised to make great advances in the coming decade in the areas of: • Drugs designed to attack cancer at its genetic roots, e.g., anti-telomerase, proapoptosis, anti-angiogenesis • Immunotherapy--therapeutic vaccines and monoclonal antibodies • Chemoprevention • Gene ...
PHS 398/2590, Other Support Format Page
... This study seeks to test a dyadic intervention to improve the quality of life (QOL) of both lung cancer patients and their family caregivers. The primary aims are: 1) to determine the effects of the intervention on patient physical and emotional quality of life, palliative care utilization, and sati ...
... This study seeks to test a dyadic intervention to improve the quality of life (QOL) of both lung cancer patients and their family caregivers. The primary aims are: 1) to determine the effects of the intervention on patient physical and emotional quality of life, palliative care utilization, and sati ...
Newsletter-January_2008___283435
... Peter B. Dirks presented his work in the “Cancer Stem Cell” plenary session. Using neurosphere proliferation as an assay for neural stem cell self-renewal, his laboratory screened a small molecule library to identify inhibitors of this process. In addition to identifying cytotoxic compounds, drugs k ...
... Peter B. Dirks presented his work in the “Cancer Stem Cell” plenary session. Using neurosphere proliferation as an assay for neural stem cell self-renewal, his laboratory screened a small molecule library to identify inhibitors of this process. In addition to identifying cytotoxic compounds, drugs k ...
MARF Presentation
... Drug Companies in 2004 invested $33.3 billion on R & D for new drugs, more than NIH budget for same year, i.e., $27.8 billion (per PhRMA) ...
... Drug Companies in 2004 invested $33.3 billion on R & D for new drugs, more than NIH budget for same year, i.e., $27.8 billion (per PhRMA) ...
Membership Guidelines - Hollings Cancer Center
... HCC Clinical Trials Office or not. All members must provide copies of IRB submissions in regards to serious adverse events, protocol deviations, and audit reports regardless if they utilize the HCC Clinical Trials Office or not. All members’ oncology clinical trials will be reviewed semi-annuall ...
... HCC Clinical Trials Office or not. All members must provide copies of IRB submissions in regards to serious adverse events, protocol deviations, and audit reports regardless if they utilize the HCC Clinical Trials Office or not. All members’ oncology clinical trials will be reviewed semi-annuall ...
Winship Invest$: Request for Pilot Grant Proposals
... 1. Prevention and Early Detection: Aims to support research into the development of cancer chemoprevention agents, biomarkers for early cancer detection, cancer-related nutrition science, development, evaluation, and optimization of safe cancer vaccines and/or clinical prevention studies. 2. Cancer ...
... 1. Prevention and Early Detection: Aims to support research into the development of cancer chemoprevention agents, biomarkers for early cancer detection, cancer-related nutrition science, development, evaluation, and optimization of safe cancer vaccines and/or clinical prevention studies. 2. Cancer ...
Interdisciplinary Research: Developing Strong Partnership
... RN-MD Collaboration • Physician’s role as ‘gatekeeper’ has changed • Nurse scientists are often better prepared educationally to conduct research than the physicians with whom they collaborate • In today’s fiscal environment, academic physicians have heavy clinical burdens and little protected rese ...
... RN-MD Collaboration • Physician’s role as ‘gatekeeper’ has changed • Nurse scientists are often better prepared educationally to conduct research than the physicians with whom they collaborate • In today’s fiscal environment, academic physicians have heavy clinical burdens and little protected rese ...
projects - Children`s Cancer Foundation
... risk of long-term neurocognitive impact due to the effects of their disease or treatment. This new role addresses a service gap for children, providing assessments at key time points: initial assessment, treatment phase, posttreatment surveillance, and long term follow up. Clinical Care: Neuropsycho ...
... risk of long-term neurocognitive impact due to the effects of their disease or treatment. This new role addresses a service gap for children, providing assessments at key time points: initial assessment, treatment phase, posttreatment surveillance, and long term follow up. Clinical Care: Neuropsycho ...
Media Release
... animal embryos. By creating these types of embryos scientists could potentially grow human organs in large animals, such as pigs and sheep, to help ease the chronic shortage of human organs available for transplantation. This research could also be used to study the causes of many human diseases. Bu ...
... animal embryos. By creating these types of embryos scientists could potentially grow human organs in large animals, such as pigs and sheep, to help ease the chronic shortage of human organs available for transplantation. This research could also be used to study the causes of many human diseases. Bu ...
Biomedical Science Research Facilities Funding Program
... The Adolescent Brain Cognitive Development Study, or the ABCD Study, which will begin in 2016. This landmark study, funded by a National Institutes of Health (NIH) grant, is a collaboration between Psychology, Psychiatry and CMRR. Researchers will study the effects of adolescent substance use on the ...
... The Adolescent Brain Cognitive Development Study, or the ABCD Study, which will begin in 2016. This landmark study, funded by a National Institutes of Health (NIH) grant, is a collaboration between Psychology, Psychiatry and CMRR. Researchers will study the effects of adolescent substance use on the ...
Ochoa, Augusto C. BIOGRAPHICAL SKETCH
... leaders and teams of supporting investigators that will undoubtedly make these programs successfully. My primary role will be to coordinate the submission and activities of this multi-disciplinary program, and facilitate the work of the clinical and scientific leaders that we have chosen to lead the ...
... leaders and teams of supporting investigators that will undoubtedly make these programs successfully. My primary role will be to coordinate the submission and activities of this multi-disciplinary program, and facilitate the work of the clinical and scientific leaders that we have chosen to lead the ...
View/print full test page
... Using sequencing and high resolution deletion/duplication analysis, the Hereditary Endocrine|ParagangliomaPheochromacytoma17 Cancer Panel analyzes 17 genes for genetic variants that predispose a person to paragangliomas (PGLs), including pheochromocytomas (PCCs), and other neuroendocrine tumors. Man ...
... Using sequencing and high resolution deletion/duplication analysis, the Hereditary Endocrine|ParagangliomaPheochromacytoma17 Cancer Panel analyzes 17 genes for genetic variants that predispose a person to paragangliomas (PGLs), including pheochromocytomas (PCCs), and other neuroendocrine tumors. Man ...
PHS 398 (Rev. 9/04), Biographical Sketch Format Page
... Karmanos Cancer Institute Wayne State University, School of Medicine. I have over 30 years of experience in cancer biology and have published numerous research articles and reviews summarizing my contributions to the field of tumor progression and metastasis. I was the first to clone galectin-3 from ...
... Karmanos Cancer Institute Wayne State University, School of Medicine. I have over 30 years of experience in cancer biology and have published numerous research articles and reviews summarizing my contributions to the field of tumor progression and metastasis. I was the first to clone galectin-3 from ...
Blastic Plasmacytoid Dendritic Cell Neoplasm
... biology of BPDCN and there is no established standard of care. The skin is the most frequently involved site of disease (80 percent of cases). However, BPDCN usually progresses to a terminal leukemic phase with bone marrow involvement and pancytopenia; the lymph nodes and spleen may also be involved ...
... biology of BPDCN and there is no established standard of care. The skin is the most frequently involved site of disease (80 percent of cases). However, BPDCN usually progresses to a terminal leukemic phase with bone marrow involvement and pancytopenia; the lymph nodes and spleen may also be involved ...
US-Brazil JCM
... Research collaborations with other Latin American countries Cancer epidemiology and morbidity resembles the trends observed in Latin American countries ...
... Research collaborations with other Latin American countries Cancer epidemiology and morbidity resembles the trends observed in Latin American countries ...
biographical sketch - Department of Biostatistics
... Biostatistics A. Personal Statement I have a broad background in biostatistics, with specific training and expertise in longitudinal data analysis and study design, Bayesian adaptive clinical trial design, Bayesian nonparametrics, missing data methods, and mediation analysis. I have served as a co-i ...
... Biostatistics A. Personal Statement I have a broad background in biostatistics, with specific training and expertise in longitudinal data analysis and study design, Bayesian adaptive clinical trial design, Bayesian nonparametrics, missing data methods, and mediation analysis. I have served as a co-i ...
Pancreas Cancer Research Program 2 3 4
... defeatist feeling among some reviewers that the disease is so dismal nothing can be done. On the other hand, there are others who feel any advance against such a terrible disease is worth pursuing.” Three members of the panel review each proposal thoroughly on five key questions (see Figure 1). They ...
... defeatist feeling among some reviewers that the disease is so dismal nothing can be done. On the other hand, there are others who feel any advance against such a terrible disease is worth pursuing.” Three members of the panel review each proposal thoroughly on five key questions (see Figure 1). They ...
biographical sketch - MD Anderson Cancer Center
... I have a broad background in biostatistics, with specific training and expertise in longitudinal data analysis and study design, Bayesian adaptive clinical trial design, missing data methods, and mediation analysis. I have served as a co-investigator or primary statistician on over 30 NIH-funded gra ...
... I have a broad background in biostatistics, with specific training and expertise in longitudinal data analysis and study design, Bayesian adaptive clinical trial design, missing data methods, and mediation analysis. I have served as a co-investigator or primary statistician on over 30 NIH-funded gra ...
biographical sketch - Department of Biostatistics
... A. Personal Statement I have a broad background in biostatistics, with specific training and expertise in longitudinal data analysis and study design, Bayesian adaptive clinical trial design, missing data methods, and mediation analysis. I have served as a co-investigator or primary statistician on ...
... A. Personal Statement I have a broad background in biostatistics, with specific training and expertise in longitudinal data analysis and study design, Bayesian adaptive clinical trial design, missing data methods, and mediation analysis. I have served as a co-investigator or primary statistician on ...
Canadian Institutes of Health Research – Institute of Cancer Research
... area, help identify promising areas of focus and prepare them for future research investments. The research proposed should be of high quality and have significant potential to improve the outlook for high fatality cancers in Canada and the world. The specific aims of this funding opportunity are to ...
... area, help identify promising areas of focus and prepare them for future research investments. The research proposed should be of high quality and have significant potential to improve the outlook for high fatality cancers in Canada and the world. The specific aims of this funding opportunity are to ...
(Nov 9, 2015) Aging Institute FY2016 Pilot
... of Pittsburgh 2) involve teams that include early stage investigators as well as established investigator 3) are led by investigators who wish to extend their work into the field of aging 4) include multiple PIs. Collaboration between a basic and clinical scientist is also strongly encouraged. Theme ...
... of Pittsburgh 2) involve teams that include early stage investigators as well as established investigator 3) are led by investigators who wish to extend their work into the field of aging 4) include multiple PIs. Collaboration between a basic and clinical scientist is also strongly encouraged. Theme ...
Ludwig Cancer Research - The University of Chicago Medicine
... Ludwig Cancer Research is an international community of distinguished scientists dedicated to preventing and controlling cancer. American businessman Daniel K. Ludwig began to support cancer research with the establishment of the Ludwig Institute for Cancer Research in 1971. Today, the scientific ef ...
... Ludwig Cancer Research is an international community of distinguished scientists dedicated to preventing and controlling cancer. American businessman Daniel K. Ludwig began to support cancer research with the establishment of the Ludwig Institute for Cancer Research in 1971. Today, the scientific ef ...
National Institutes of Health
The National Institutes of Health (NIH) is a biomedical research facility primarily located in Bethesda, Maryland. An agency of the United States Department of Health and Human Services, it is the primary agency of the United States government responsible for biomedical and health-related research. The NIH both conducts its own scientific research through its Intramural Research Program (IRP) and provides major biomedical research funding to non-NIH research facilities through its Extramural Research Program.With 1,200 principal investigators and more than 4,000 postdoctoral fellows in basic, translational, and clinical research, the IRP is the largest biomedical research institution in the world, while, as of 2003, the extramural arm provided 28% of biomedical research funding spent annually in the U.S., or about US$26.4 billion.The NIH comprises 27 separate institutes and centers that conduct research in different disciplines of biomedical science. The IRP is responsible for many scientific accomplishments, including the discovery of fluoride to prevent tooth decay, the use of lithium to manage bipolar disorder, and the creation of vaccines against hepatitis, Haemophilus influenzae (HIB) and human papillomavirus (HPV).